Dominick Colangelo
Insider
- 2024
- Jun 4, 2026
- 5
Summary
Latest filing:
Dominick Colangelo files SEC Form 4 reports at Trevi Therapeutics, Inc. (TRVI). 5 SEC Form 4 filings on record going back to 2024, most recently on 4 June 2026. Most recent open-market trade: sold $944K of VCEL on 15 November 2024. Lifetime open-market sales: $3.35M.
Recent transactions
14The latest 14 SEC Form 4 transactions reported by Dominick Colangelo.
Trading pattern
InsiderAlpha's records for Dominick Colangelo go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. 12 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dominick Colangelo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Halpin - $2.04M in VCEL purchases and sales in the last 12 months
- Sean C. Flynn - $2.04M in VCEL purchases and sales in the last 12 months
- Kevin F. McLaughlin - $1.05M in VCEL purchases and sales in the last 12 months
- Jonathan Mark Hopper - $789K in VCEL purchases and sales in the last 12 months
- Michael Thomas Heffernan - $596K in TRVI purchases and sales in the last 12 months
- Jonathan Siegal - $531K in VCEL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dominick Colangelo?
Dominick Colangelo is a corporate insider of Trevi Therapeutics, Inc. (TRVI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dominick Colangelo last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 5 filings going back to 2024.
Has Dominick Colangelo been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($3.35M) across all tracked filings.